US expert panel approves Alzheimer's scan

Afp
Monday 24 January 2011 01:00 GMT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

An advisory committee to the US Food and Drug Administration has approved a new brain scan procedure for detecting Alzheimer's disease, as long as doctors receive additional training to use it.

The process involves injecting a chemical called Amyvid, made by US pharmaceutical giant Eli Lilly, followed by an imaging scan that can detect plaque, or beta-amyloid aggregates, that indicate the presence of Alzheimer's.

The FDA expert panel, whose rulings the FDA does not have to follow but typically does, first voted against approving (13 against and three in favor) the test in their meeting on Thursday.

But the panel inserted a condition that was not presented by the FDA - that a training program would be implemented that shows accurate diagnosis can be made in the general population - and approved that unanimously, 16-0.

Earlier this week, a study published in the Journal of the American Medical Association said the molecular imaging procedure could help lead to better treatment and diagnosis of Alzheimer's in living patients.

There is no cure for the degenerative brain condition that affects around five million Americans.

ksh/ao

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in